Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZFP14 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | TCERG1L | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
mRNA | ZNF260 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | BSN | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
mRNA | BEND5 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-10 |
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-10 |
mRNA | TMOD2 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-10 |